It is known that a minor subpopulation of CD8+ T cells expressing NKp30-activating receptor exhibits a high potential for natural killer cell activity against tumor formations, and that IL-15 is able to induce the expression of NKp30 in a population of CD8+ T cells de novo [33]. Here, NCR3 is linked to neoplasm.